Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Chemical Compound Review:

AG-K-29423 1-cyclopropyl-8- (difluoromethoxy)-7-(1...

Synonyms: SureCN2897686, CTK7B7265, AC1LA1OP, Des-fluoro(6) quinolone

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of AIDS-094950

Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and Hospitals [1].
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model [2].
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria [3].
Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species [4].
The des-fluoro(6) quinolone BMS-284756 (T-3811ME), fluoroquinolones (trovafloxacin, levofloxacin) and cell wall-active agents (beta-lactams, vancomycin) were evaluated against Enterobacteriaceae, Staphylococcus aureus, streptococci, and Enterococcus faecalis [5].

High impact information on AIDS-094950

DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases [6].
The in vitro activity of BMS-284756 (previously T-3811ME), a des-fluoro(6) quinolone, was investigated and compared with those of six other antimicrobial agents [7].

Chemical compound and disease context of AIDS-094950

Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance [8].

References

Molecular Characteristics and In Vitro Susceptibility to Antimicrobial Agents, Including the Des-Fluoro(6) Quinolone DX-619, of Panton-Valentine Leucocidin-Positive Methicillin-Resistant Staphylococcus aureus Isolates from the Community and Hospitals. Yamamoto, T., Dohmae, S., Saito, K., Otsuka, T., Takano, T., Chiba, M., Fujikawa, K., Tanaka, M. Antimicrob. Agents Chemother. (2006) [Pubmed]
In vivo efficacies and pharmacokinetics of DX-619, a novel des-fluoro(6) quinolone, against Streptococcus pneumoniae in a mouse lung infection model. Fukuda, Y., Yanagihara, K., Ohno, H., Higashiyama, Y., Miyazaki, Y., Tsukamoto, K., Hirakata, Y., Tomono, K., Mizuta, Y., Tashiro, T., Kohno, S. Antimicrob. Agents Chemother. (2006) [Pubmed]
In vitro activities of a new des-fluoro(6) quinolone, garenoxacin, against clinical anaerobic bacteria. Liebetrau, A., Rodloff, A.C., Behra-Miellet, J., Dubreuil, L. Antimicrob. Agents Chemother. (2003) [Pubmed]
Synergistic activity of the novel des-fluoro(6) quinolone, garenoxacin (BMS-284756), in combination with other antimicrobial agents against Pseudomonas aeruginosa and related species. Fung-Tomc, J.C., Gradelski, E., Valera, L., Huczko, E., Bonner, D.P. Int. J. Antimicrob. Agents (2002) [Pubmed]
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams. Gradelski, E., Valera, L., Kolek, B., Bonner, D., Fung-Tomc, J. Int. J. Antimicrob. Agents (2001) [Pubmed]
DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases. Strahilevitz, J., Truong-Bolduc, Q.C., Hooper, D.C. Antimicrob. Agents Chemother. (2005) [Pubmed]
The in vitro activity of BMS-284756, a new des-fluorinated quinolone. Weller, T.M., Andrews, J.M., Jevons, G., Wise, R. J. Antimicrob. Chemother. (2002) [Pubmed]
Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance. Low, D.E., Muller, M., Duncan, C.L., Willey, B.M., de Azavedo, J.C., McGeer, A., Kreiswirth, B.N., Pong-Porter, S., Bast, D.J. Antimicrob. Agents Chemother. (2002) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.